Switching From High-Dose Eculizumab to Ravulizumab in Paroxysmal Nocturnal Hemoglobinuria: A Case Report

Hemasphere. 2020 Aug 4;4(4):e455. doi: 10.1097/HS9.0000000000000455. eCollection 2020 Aug.

Authors

Wolfgang Füreder¹, Peter Valent¹

Affiliation

¹ Department of Internal Medicine I, Division of Hematology and Hemostaseology; Medical University of Vienna, Austria.

No abstract available

Publication types

Case Reports